Ubs Group Ag Calliditas Therapeutics Ab Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Calliditas Therapeutics Ab stock. As of the latest transaction made, Ubs Group Ag holds 10,756 shares of CALT stock, worth $430,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,756

Holding current value

$430,240

% of portfolio

0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$17.65 - $41.41 $189,843 - $445,405	10,756 New	10,756 $419,000
Q4 2023 Feb 09, 2024	BUY	$15.79 - $28.99 $14,384 - $26,409	911 Added 2221.95%	952 $24,000
Q3 2023 Nov 09, 2023	SELL	$15.68 - $20.38 $2,132 - $2,771	-136 Reduced 76.84%	41 $0
Q2 2023 Aug 11, 2023	SELL	$15.7 - $25.61 $2,025 - $3,303	-129 Reduced 42.16%	177 $2,000
Q1 2023 May 12, 2023	SELL	$16.8 - $25.24 $2,402 - $3,609	-143 Reduced 31.85%	306 $7,000
Q4 2022 Feb 08, 2023	BUY	$11.5 - $19.6 $2,185 - $3,724	190 Added 73.36%	449 $7,000
Q3 2022 Nov 10, 2022	SELL	$14.12 - $22.49 $5,323 - $8,478	-377 Reduced 59.28%	259 $4,000
Q2 2022 Aug 10, 2022	SELL	$12.85 - $20.36 $10,973 - $17,387	-854 Reduced 57.32%	636 $11,000
Q1 2022 May 16, 2022	BUY	$15.14 - $25.55 $499 - $843	33 Added 2.26%	1,490 $29,000
Q4 2021 Feb 14, 2022	BUY	$15.04 - $26.32 $19,476 - $34,084	1,295 Added 799.38%	1,457 $36,000
Q3 2021 Nov 15, 2021	BUY	$21.03 - $33.19 $3,175 - $5,011	151 Added 1372.73%	162 $4,000
Q2 2021 Aug 13, 2021	SELL	$26.02 - $31.17 $17,693 - $21,195	-680 Reduced 98.41%	11 $0
Q1 2021 May 12, 2021	BUY	$27.01 - $32.92 $18,663 - $22,747	691 New	691 $19,000
Q4 2020 Feb 11, 2021	SELL	$23.34 - $36.65 $19,512 - $30,639	-836 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$21.61 - $25.69 $18,065 - $21,476	836 New	836 $20,000

Others Institutions Holding CALT

# of Institutions

Shares Held

843K

Call Options Held

8.5K

Put Options Held

26.6K

Bvf Inc San Francisco, CA

750K
Shares

$30 Million
0.89% of portfolio
Ironwood Investment Management LLC Boston, MA

25.6K
Shares

$1.03 Million
0.56% of portfolio
Optiver Holding B.V. Amsterdam, P7

22.3K
Shares

$893,440
0.02% of portfolio
Crossmark Global Holdings, Inc.

16.1K
Shares

$644,680
0.01% of portfolio
Pender Fund Capital Management Ltd. Vancouver, A1

6K
Shares

$240,000
0.2% of portfolio

View Full List

About Calliditas Therapeutics AB

Ticker CALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,624,800
Market Cap $1.06B
Description
Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...

More about CALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account